Open AccessPrenatal Protease Inhibitor Use and Risk of Preterm Birth among HIV‐Infected Women Initiating Antiretroviral Drugs during Pregnancy
Author(s) -
Kunjal Patel,
David E. Shapiro,
Susan B. Brogly,
Elizabeth Livingston,
Alice Stek,
Arlene Bardeguez,
Ruth Tuomala
Publication year - 2010
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/651232
Subject(s) - pregnancy , medicine , protease inhibitor (pharmacology) , obstetrics , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , virology , biology , genetics
Conflicting results have been reported among studies of protease inhibitor (PI) use during pregnancy and preterm birth. Uncontrolled confounding by indication may explain some of the differences among studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom